nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—SLC22A3—Progesterone—uterine cancer	0.456	1	CbGbCtD
Adefovir Dipivoxil—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.0149	0.103	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide Metabolism—POLD1—uterine cancer	0.0118	0.0821	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.0103	0.0715	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide Metabolism—RRM2—uterine cancer	0.00987	0.0685	CbGpPWpGaD
Adefovir Dipivoxil—AK2—myometrium—uterine cancer	0.00928	0.0529	CbGeAlD
Adefovir Dipivoxil—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—RRM2—uterine cancer	0.00781	0.0542	CbGpPWpGaD
Adefovir Dipivoxil—NME1-NME2—female reproductive system—uterine cancer	0.00714	0.0407	CbGeAlD
Adefovir Dipivoxil—AK4—myometrium—uterine cancer	0.00687	0.0392	CbGeAlD
Adefovir Dipivoxil—AK2—mammalian vulva—uterine cancer	0.00632	0.036	CbGeAlD
Adefovir Dipivoxil—AK2—uterus—uterine cancer	0.00602	0.0343	CbGeAlD
Adefovir Dipivoxil—Foetor hepaticus—Progesterone—uterine cancer	0.0055	0.0249	CcSEcCtD
Adefovir Dipivoxil—AK4—uterine cervix—uterine cancer	0.00534	0.0305	CbGeAlD
Adefovir Dipivoxil—NME2—epithelium—uterine cancer	0.00527	0.03	CbGeAlD
Adefovir Dipivoxil—NME1—renal system—uterine cancer	0.00519	0.0296	CbGeAlD
Adefovir Dipivoxil—AK4—decidua—uterine cancer	0.00509	0.029	CbGeAlD
Adefovir Dipivoxil—AK4—renal system—uterine cancer	0.005	0.0285	CbGeAlD
Adefovir Dipivoxil—Foetor hepaticus—Medroxyprogesterone Acetate—uterine cancer	0.00498	0.0226	CcSEcCtD
Adefovir Dipivoxil—AK2—female gonad—uterine cancer	0.00492	0.0281	CbGeAlD
Adefovir Dipivoxil—AK2—vagina—uterine cancer	0.00489	0.0279	CbGeAlD
Adefovir Dipivoxil—NME2—renal system—uterine cancer	0.00489	0.0279	CbGeAlD
Adefovir Dipivoxil—AK4—endometrium—uterine cancer	0.00483	0.0276	CbGeAlD
Adefovir Dipivoxil—AK4—mammalian vulva—uterine cancer	0.00467	0.0267	CbGeAlD
Adefovir Dipivoxil—NME1—uterus—uterine cancer	0.00462	0.0264	CbGeAlD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—RRM2—uterine cancer	0.0046	0.0319	CbGpPWpGaD
Adefovir Dipivoxil—Liver disorder—Progesterone—uterine cancer	0.00458	0.0207	CcSEcCtD
Adefovir Dipivoxil—AK4—uterus—uterine cancer	0.00445	0.0254	CbGeAlD
Adefovir Dipivoxil—Myopathy—Progesterone—uterine cancer	0.00445	0.0201	CcSEcCtD
Adefovir Dipivoxil—NME1-NME2—lymph node—uterine cancer	0.00418	0.0238	CbGeAlD
Adefovir Dipivoxil—NME1—female reproductive system—uterine cancer	0.00415	0.0237	CbGeAlD
Adefovir Dipivoxil—Liver disorder—Medroxyprogesterone Acetate—uterine cancer	0.00415	0.0188	CcSEcCtD
Adefovir Dipivoxil—AK4—female reproductive system—uterine cancer	0.004	0.0228	CbGeAlD
Adefovir Dipivoxil—NME2—female reproductive system—uterine cancer	0.00391	0.0223	CbGeAlD
Adefovir Dipivoxil—NME1—female gonad—uterine cancer	0.00378	0.0216	CbGeAlD
Adefovir Dipivoxil—ABCC5—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.0037	0.0257	CbGpPWpGaD
Adefovir Dipivoxil—AK4—female gonad—uterine cancer	0.00364	0.0208	CbGeAlD
Adefovir Dipivoxil—AK4—vagina—uterine cancer	0.00362	0.0207	CbGeAlD
Adefovir Dipivoxil—NME2—female gonad—uterine cancer	0.00356	0.0203	CbGeAlD
Adefovir Dipivoxil—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.00349	0.0158	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Progesterone—uterine cancer	0.00326	0.0147	CcSEcCtD
Adefovir Dipivoxil—NME1—Levonorgestrel—Progesterone—uterine cancer	0.00319	1	CbGdCrCtD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—RRM2—uterine cancer	0.00319	0.0221	CbGpPWpGaD
Adefovir Dipivoxil—AK2—lymph node—uterine cancer	0.00317	0.0181	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Progesterone—uterine cancer	0.00312	0.0141	CcSEcCtD
Adefovir Dipivoxil—ABCC5—uterine cervix—uterine cancer	0.00303	0.0173	CbGeAlD
Adefovir Dipivoxil—ABCC5—decidua—uterine cancer	0.00289	0.0165	CbGeAlD
Adefovir Dipivoxil—Hepatocellular injury—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.0128	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—myometrium—uterine cancer	0.00279	0.0159	CbGeAlD
Adefovir Dipivoxil—Nephropathy toxic—Etoposide—uterine cancer	0.00278	0.0126	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00278	0.0126	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—HMGA1—uterine cancer	0.00266	0.0184	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	0.00263	0.0183	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0026	0.018	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Progesterone—uterine cancer	0.00259	0.0117	CcSEcCtD
Adefovir Dipivoxil—ABCC4—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.00257	0.0178	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Progesterone—uterine cancer	0.00252	0.0114	CcSEcCtD
Adefovir Dipivoxil—NME1—lymph node—uterine cancer	0.00243	0.0139	CbGeAlD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—RRM2—uterine cancer	0.00242	0.0168	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.0106	CcSEcCtD
Adefovir Dipivoxil—AK4—lymph node—uterine cancer	0.00234	0.0134	CbGeAlD
Adefovir Dipivoxil—NME2—lymph node—uterine cancer	0.00229	0.0131	CbGeAlD
Adefovir Dipivoxil—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0103	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—uterine cervix—uterine cancer	0.00217	0.0124	CbGeAlD
Adefovir Dipivoxil—SLC22A3—smooth muscle tissue—uterine cancer	0.00211	0.012	CbGeAlD
Adefovir Dipivoxil—Liver function test abnormal—Progesterone—uterine cancer	0.00209	0.00946	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—IGF1R—uterine cancer	0.00209	0.0145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—female gonad—uterine cancer	0.00207	0.0118	CbGeAlD
Adefovir Dipivoxil—ABCC5—vagina—uterine cancer	0.00206	0.0117	CbGeAlD
Adefovir Dipivoxil—SLC22A3—renal system—uterine cancer	0.00203	0.0116	CbGeAlD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—HMGA1—uterine cancer	0.00201	0.014	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Progesterone—uterine cancer	0.002	0.00904	CcSEcCtD
Adefovir Dipivoxil—ABCC4—renal system—uterine cancer	0.00197	0.0112	CbGeAlD
Adefovir Dipivoxil—SLC22A3—endometrium—uterine cancer	0.00196	0.0112	CbGeAlD
Adefovir Dipivoxil—SLC22A8—renal system—uterine cancer	0.00195	0.0111	CbGeAlD
Adefovir Dipivoxil—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.0087	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—mammalian vulva—uterine cancer	0.0019	0.0108	CbGeAlD
Adefovir Dipivoxil—Kidney function abnormal—Epirubicin—uterine cancer	0.00185	0.00838	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00819	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0018	0.0125	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Dactinomycin—uterine cancer	0.00178	0.00806	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Progesterone—uterine cancer	0.00177	0.00802	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—uterine cancer	0.00175	0.0122	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—uterus—uterine cancer	0.00175	0.01	CbGeAlD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—SMAD3—uterine cancer	0.00174	0.0121	CbGpPWpGaD
Adefovir Dipivoxil—Kidney function abnormal—Doxorubicin—uterine cancer	0.00171	0.00775	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Progesterone—uterine cancer	0.0017	0.0077	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Carboplatin—uterine cancer	0.00167	0.00758	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Progesterone—uterine cancer	0.00165	0.00747	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—BIRC5—uterine cancer	0.00164	0.0114	CbGpPWpGaD
Adefovir Dipivoxil—Sinusitis—Progesterone—uterine cancer	0.00164	0.00741	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—female reproductive system—uterine cancer	0.00162	0.00927	CbGeAlD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—uterine cancer	0.00161	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00726	CcSEcCtD
Adefovir Dipivoxil—ABCC4—female reproductive system—uterine cancer	0.00158	0.00899	CbGeAlD
Adefovir Dipivoxil—Hepatitis—Progesterone—uterine cancer	0.00157	0.00709	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Progesterone—uterine cancer	0.00155	0.00704	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Progesterone—uterine cancer	0.00155	0.007	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00698	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Progesterone—uterine cancer	0.00154	0.00697	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Epirubicin—uterine cancer	0.00154	0.00697	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Progesterone—uterine cancer	0.00154	0.00695	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00677	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00672	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—female gonad—uterine cancer	0.00148	0.00843	CbGeAlD
Adefovir Dipivoxil—Liver function test abnormal—Dactinomycin—uterine cancer	0.00148	0.00669	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.00147	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—vagina—uterine cancer	0.00147	0.00838	CbGeAlD
Adefovir Dipivoxil—Serum creatinine increased—Epirubicin—uterine cancer	0.00145	0.00658	CcSEcCtD
Adefovir Dipivoxil—ABCC4—female gonad—uterine cancer	0.00143	0.00818	CbGeAlD
Adefovir Dipivoxil—Hypophosphataemia—Doxorubicin—uterine cancer	0.00142	0.00645	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00643	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CDH1—uterine cancer	0.00142	0.00983	CbGpPWpGaD
Adefovir Dipivoxil—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00638	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.00635	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.00631	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—uterine cancer	0.00139	0.00966	CbGpPWpGaD
Adefovir Dipivoxil—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00139	0.0063	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Progesterone—uterine cancer	0.00136	0.00617	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Doxorubicin—uterine cancer	0.00135	0.00609	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Progesterone—uterine cancer	0.00134	0.00608	CcSEcCtD
Adefovir Dipivoxil—ABCC5—lymph node—uterine cancer	0.00133	0.00758	CbGeAlD
Adefovir Dipivoxil—Back pain—Progesterone—uterine cancer	0.00132	0.00597	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—SMAD3—uterine cancer	0.00132	0.00914	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00131	0.00911	CbGpPWpGaD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—CTNNB1—uterine cancer	0.00129	0.00898	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Progesterone—uterine cancer	0.00126	0.00571	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—BIRC5—uterine cancer	0.00125	0.00864	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00559	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00551	CcSEcCtD
Adefovir Dipivoxil—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00541	CcSEcCtD
Adefovir Dipivoxil—Cough—Progesterone—uterine cancer	0.00119	0.00539	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Progesterone—uterine cancer	0.00116	0.00526	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Progesterone—uterine cancer	0.00116	0.00526	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00115	0.00522	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00517	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Dactinomycin—uterine cancer	0.00111	0.00501	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Epirubicin—uterine cancer	0.0011	0.005	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Dactinomycin—uterine cancer	0.0011	0.00497	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Progesterone—uterine cancer	0.00109	0.00494	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Progesterone—uterine cancer	0.00108	0.00489	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Progesterone—uterine cancer	0.00106	0.0048	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00476	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00105	0.00476	CcSEcCtD
Adefovir Dipivoxil—NME1—Arf6 trafficking events—CTNNB1—uterine cancer	0.00105	0.00725	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00473	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—uterine cancer	0.00103	0.00713	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00102	0.00462	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Doxorubicin—uterine cancer	0.00102	0.00462	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00101	0.00459	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000989	0.00448	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00447	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Progesterone—uterine cancer	0.00098	0.00443	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00098	0.00443	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Epirubicin—uterine cancer	0.000977	0.00442	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Progesterone—uterine cancer	0.000967	0.00438	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000961	0.00435	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Progesterone—uterine cancer	0.000961	0.00435	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—lymph node—uterine cancer	0.00095	0.00542	CbGeAlD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000944	0.00655	CbGpPWpGaD
Adefovir Dipivoxil—Creatinine increased—Epirubicin—uterine cancer	0.00094	0.00425	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Epirubicin—uterine cancer	0.000934	0.00423	CcSEcCtD
Adefovir Dipivoxil—ABCC4—lymph node—uterine cancer	0.000922	0.00526	CbGeAlD
Adefovir Dipivoxil—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000919	0.00416	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00091	0.00631	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Progesterone—uterine cancer	0.00091	0.00412	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Doxorubicin—uterine cancer	0.000904	0.00409	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Defective B3GAT3 causes JDSSDHD—DCN—uterine cancer	0.000904	0.00627	CbGpPWpGaD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—uterine cancer	0.000895	0.00405	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Dactinomycin—uterine cancer	0.000891	0.00403	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—uterine cancer	0.00089	0.00617	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000888	0.00402	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—SRD5A2—uterine cancer	0.000884	0.00613	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—NDUFB11—uterine cancer	0.000884	0.00613	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Progesterone—uterine cancer	0.00088	0.00398	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Progesterone—uterine cancer	0.00088	0.00398	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—uterine cancer	0.000879	0.00398	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Etoposide—uterine cancer	0.000877	0.00397	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00397	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000875	0.00607	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000871	0.00394	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Etoposide—uterine cancer	0.00087	0.00394	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—uterine cancer	0.000869	0.00394	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—uterine cancer	0.000864	0.00391	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—EP300—uterine cancer	0.000847	0.00587	CbGpPWpGaD
Adefovir Dipivoxil—Hepatobiliary disease—Etoposide—uterine cancer	0.000844	0.00382	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—uterine cancer	0.000828	0.00375	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000825	0.00373	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Dactinomycin—uterine cancer	0.000821	0.00371	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—NFE2L2—uterine cancer	0.000816	0.00566	CbGpPWpGaD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—uterine cancer	0.000813	0.00368	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Progesterone—uterine cancer	0.000799	0.00361	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000797	0.00361	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000797	0.00361	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	0.000794	0.00551	CbGpPWpGaD
Adefovir Dipivoxil—Urinary tract disorder—Etoposide—uterine cancer	0.000791	0.00358	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Progesterone—uterine cancer	0.000787	0.00356	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Etoposide—uterine cancer	0.000786	0.00356	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GPX3—uterine cancer	0.000778	0.0054	CbGpPWpGaD
Adefovir Dipivoxil—Thrombocytopenia—Dactinomycin—uterine cancer	0.00077	0.00349	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Progesterone—uterine cancer	0.000761	0.00345	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Dactinomycin—uterine cancer	0.00075	0.00339	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—uterine cancer	0.000743	0.00336	CcSEcCtD
Adefovir Dipivoxil—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—uterine cancer	0.000727	0.00504	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000724	0.00328	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—uterine cancer	0.000723	0.00327	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000717	0.00324	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000714	0.00323	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	0.000712	0.00494	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Progesterone—uterine cancer	0.000708	0.0032	CcSEcCtD
Adefovir Dipivoxil—Rash—Progesterone—uterine cancer	0.000702	0.00318	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Progesterone—uterine cancer	0.000701	0.00317	CcSEcCtD
Adefovir Dipivoxil—Headache—Progesterone—uterine cancer	0.000697	0.00316	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00069	0.00312	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000687	0.00311	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Dactinomycin—uterine cancer	0.000684	0.0031	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—uterine cancer	0.000682	0.00309	CcSEcCtD
Adefovir Dipivoxil—Back pain—Etoposide—uterine cancer	0.000675	0.00305	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—uterine cancer	0.000669	0.00303	CcSEcCtD
Adefovir Dipivoxil—Nausea—Progesterone—uterine cancer	0.000661	0.00299	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—uterine cancer	0.000654	0.00454	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Etoposide—uterine cancer	0.000645	0.00292	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000643	0.00291	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—EP300—uterine cancer	0.000642	0.00445	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000641	0.0029	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—STAR—uterine cancer	0.000639	0.00443	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKR1B1—uterine cancer	0.000639	0.00443	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000636	0.00288	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000635	0.00288	CcSEcCtD
Adefovir Dipivoxil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000632	0.00286	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—uterine cancer	0.000631	0.00286	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Dactinomycin—uterine cancer	0.000622	0.00282	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Dactinomycin—uterine cancer	0.000622	0.00282	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—NDUFB11—uterine cancer	0.000612	0.00425	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—SRD5A2—uterine cancer	0.000612	0.00425	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Etoposide—uterine cancer	0.000609	0.00276	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—uterine cancer	0.000608	0.00275	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000606	0.0042	CbGpPWpGaD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—uterine cancer	0.000599	0.00271	CcSEcCtD
Adefovir Dipivoxil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000599	0.00271	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Etoposide—uterine cancer	0.000594	0.00269	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00059	0.00267	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000573	0.00259	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—NFE2L2—uterine cancer	0.000566	0.00392	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Dactinomycin—uterine cancer	0.000564	0.00255	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—uterine cancer	0.000563	0.00255	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Etoposide—uterine cancer	0.000557	0.00252	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—uterine cancer	0.000555	0.00251	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Etoposide—uterine cancer	0.000553	0.0025	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—uterine cancer	0.00055	0.00249	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Etoposide—uterine cancer	0.000543	0.00246	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GPX3—uterine cancer	0.00054	0.00374	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Dactinomycin—uterine cancer	0.000538	0.00244	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	0.000531	0.00368	CbGpPWpGaD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00053	0.0024	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—uterine cancer	0.000509	0.0023	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—uterine cancer	0.000508	0.0023	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—POLD1—uterine cancer	0.000501	0.00348	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Dactinomycin—uterine cancer	0.0005	0.00226	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—uterine cancer	0.000499	0.00346	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Dactinomycin—uterine cancer	0.000496	0.00225	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Etoposide—uterine cancer	0.000495	0.00224	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—uterine cancer	0.000492	0.00223	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Etoposide—uterine cancer	0.000492	0.00223	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—uterine cancer	0.000488	0.00221	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—DCN—uterine cancer	0.000485	0.00336	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Epirubicin—uterine cancer	0.000477	0.00216	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—uterine cancer	0.000473	0.00214	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—uterine cancer	0.00047	0.00213	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—uterine cancer	0.000469	0.00213	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—AKR1C1—uterine cancer	0.000469	0.00325	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Dactinomycin—uterine cancer	0.000467	0.00212	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Etoposide—uterine cancer	0.000466	0.00211	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—NDUFB11—uterine cancer	0.000464	0.00322	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—SRD5A2—uterine cancer	0.000464	0.00322	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—uterine cancer	0.000459	0.00319	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Doxorubicin—uterine cancer	0.000455	0.00206	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—uterine cancer	0.000451	0.00204	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Etoposide—uterine cancer	0.00045	0.00204	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Etoposide—uterine cancer	0.00045	0.00204	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Epirubicin—uterine cancer	0.000449	0.00203	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—uterine cancer	0.000446	0.00202	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—uterine cancer	0.000444	0.00201	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—AKR1B1—uterine cancer	0.000443	0.00307	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—STAR—uterine cancer	0.000443	0.00307	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Doxorubicin—uterine cancer	0.000441	0.002	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—uterine cancer	0.000441	0.002	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—uterine cancer	0.00044	0.00199	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000438	0.00198	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—uterine cancer	0.000434	0.00197	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—RRM2—uterine cancer	0.000418	0.0029	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—uterine cancer	0.000416	0.00188	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—uterine cancer	0.000413	0.00187	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—uterine cancer	0.00041	0.00186	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Etoposide—uterine cancer	0.000408	0.00185	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—uterine cancer	0.000408	0.00185	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—uterine cancer	0.000407	0.00184	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—DCN—uterine cancer	0.000406	0.00281	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Etoposide—uterine cancer	0.000403	0.00182	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—uterine cancer	0.000391	0.00177	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Etoposide—uterine cancer	0.00039	0.00176	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	0.000389	0.0027	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000387	0.00268	CbGpPWpGaD
Adefovir Dipivoxil—Flatulence—Epirubicin—uterine cancer	0.000385	0.00174	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYP11A1—uterine cancer	0.000382	0.00265	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Epirubicin—uterine cancer	0.000378	0.00171	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Etoposide—uterine cancer	0.000362	0.00164	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—uterine cancer	0.000362	0.00164	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—uterine cancer	0.000361	0.00164	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—AKR1C3—uterine cancer	0.000361	0.0025	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	0.000361	0.0025	CbGpPWpGaD
Adefovir Dipivoxil—Rash—Etoposide—uterine cancer	0.000359	0.00163	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Etoposide—uterine cancer	0.000359	0.00162	CcSEcCtD
Adefovir Dipivoxil—Headache—Etoposide—uterine cancer	0.000357	0.00161	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Doxorubicin—uterine cancer	0.000357	0.00161	CcSEcCtD
Adefovir Dipivoxil—Back pain—Doxorubicin—uterine cancer	0.00035	0.00158	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—POLD1—uterine cancer	0.000347	0.00241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—uterine cancer	0.000346	0.0024	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Epirubicin—uterine cancer	0.000341	0.00154	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	0.000341	0.00236	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Etoposide—uterine cancer	0.000338	0.00153	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—STAR—uterine cancer	0.000336	0.00233	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKR1B1—uterine cancer	0.000336	0.00233	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Doxorubicin—uterine cancer	0.000334	0.00151	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—uterine cancer	0.000333	0.00151	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—uterine cancer	0.000333	0.00151	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	0.000332	0.0023	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000331	0.0015	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—AKR1C1—uterine cancer	0.000325	0.00225	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	0.000317	0.0022	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Doxorubicin—uterine cancer	0.000316	0.00143	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—uterine cancer	0.000313	0.00142	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—uterine cancer	0.000312	0.00141	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00031	0.00215	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Epirubicin—uterine cancer	0.00031	0.0014	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—uterine cancer	0.000308	0.00139	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—uterine cancer	0.000308	0.00139	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000306	0.00138	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Epirubicin—uterine cancer	0.000304	0.00138	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—FGFR2—uterine cancer	0.000301	0.00209	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	0.0003	0.00208	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000291	0.00132	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—RRM2—uterine cancer	0.00029	0.00201	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—uterine cancer	0.00029	0.00131	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—uterine cancer	0.000289	0.00131	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—uterine cancer	0.000287	0.0013	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Doxorubicin—uterine cancer	0.000281	0.00127	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—DCN—uterine cancer	0.000281	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—STK11—uterine cancer	0.000281	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—CYP19A1—uterine cancer	0.000281	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—uterine cancer	0.000281	0.00127	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00028	0.00194	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—uterine cancer	0.000277	0.00126	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000276	0.00125	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000269	0.00122	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000268	0.00186	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP11A1—uterine cancer	0.000265	0.00184	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—POLD1—uterine cancer	0.000263	0.00183	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—uterine cancer	0.000261	0.00118	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—uterine cancer	0.00026	0.00118	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—uterine cancer	0.000257	0.00116	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	0.000255	0.00177	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000255	0.00115	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—uterine cancer	0.000252	0.00114	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—uterine cancer	0.000252	0.00114	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—NDUFB11—uterine cancer	0.000251	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—SRD5A2—uterine cancer	0.000251	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKR1C3—uterine cancer	0.00025	0.00174	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKR1C1—uterine cancer	0.000246	0.00171	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000241	0.00109	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	0.000234	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000233	0.00162	CbGpPWpGaD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—uterine cancer	0.000233	0.00106	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—uterine cancer	0.000233	0.00106	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Disease—AKR1B10—uterine cancer	0.000233	0.00161	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Epirubicin—uterine cancer	0.000229	0.00104	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CCL2—uterine cancer	0.000227	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	0.000227	0.00157	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Epirubicin—uterine cancer	0.000226	0.00102	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—VEGFA—uterine cancer	0.000225	0.00156	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—RRM2—uterine cancer	0.00022	0.00152	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—uterine cancer	0.000218	0.000988	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000215	0.00149	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—DCN—uterine cancer	0.000213	0.00148	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—uterine cancer	0.000212	0.000959	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—MTHFR—uterine cancer	0.000211	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Doxorubicin—uterine cancer	0.000209	0.000946	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Epirubicin—uterine cancer	0.000203	0.000919	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—uterine cancer	0.000202	0.000915	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—uterine cancer	0.000201	0.000911	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—uterine cancer	0.000201	0.00091	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—SRD5A2—uterine cancer	0.000201	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NDUFB11—uterine cancer	0.000201	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP11A1—uterine cancer	0.000201	0.00139	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Epirubicin—uterine cancer	0.0002	0.000905	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—STK11—uterine cancer	0.000195	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—CYP19A1—uterine cancer	0.000195	0.00135	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—RNF43—uterine cancer	0.000193	0.00134	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	0.000191	0.00133	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKR1C3—uterine cancer	0.00019	0.00132	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—uterine cancer	0.00019	0.000858	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—uterine cancer	0.000188	0.00085	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—uterine cancer	0.000186	0.000843	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—uterine cancer	0.000186	0.000842	CcSEcCtD
Adefovir Dipivoxil—Headache—Doxorubicin—uterine cancer	0.000185	0.000837	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—AKR1B1—uterine cancer	0.000181	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—STAR—uterine cancer	0.000181	0.00126	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—uterine cancer	0.000175	0.000794	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Hemostasis—IRF1—uterine cancer	0.000174	0.00121	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—CTNNB1—uterine cancer	0.000165	0.00115	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKR1C1—uterine cancer	0.000159	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—STK11—uterine cancer	0.000148	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP19A1—uterine cancer	0.000148	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—MTHFR—uterine cancer	0.000146	0.00102	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—STAR—uterine cancer	0.000145	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKR1B1—uterine cancer	0.000145	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—POLD1—uterine cancer	0.000142	0.000986	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DCN—uterine cancer	0.000137	0.000953	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKR1C1—uterine cancer	0.000133	0.000922	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKR1C3—uterine cancer	0.000122	0.000848	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HMGA1—uterine cancer	0.000119	0.000826	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—RRM2—uterine cancer	0.000119	0.000822	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTEN—uterine cancer	0.000118	0.000815	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—DCN—uterine cancer	0.000115	0.000798	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—POLD1—uterine cancer	0.000114	0.000791	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—EP300—uterine cancer	0.000112	0.000778	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—MTHFR—uterine cancer	0.000111	0.00077	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FBXW7—uterine cancer	0.000109	0.000756	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP11A1—uterine cancer	0.000108	0.000752	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKR1C1—uterine cancer	0.000107	0.00074	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKR1C3—uterine cancer	0.000102	0.00071	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	9.99e-05	0.000693	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—RRM2—uterine cancer	9.51e-05	0.000659	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DCN—uterine cancer	9.23e-05	0.00064	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP11A1—uterine cancer	8.7e-05	0.000603	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN2B—uterine cancer	8.54e-05	0.000592	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PIK3CA—uterine cancer	8.29e-05	0.000575	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKR1C3—uterine cancer	8.21e-05	0.00057	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTEN—uterine cancer	8.15e-05	0.000565	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP19A1—uterine cancer	7.98e-05	0.000553	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—STK11—uterine cancer	7.98e-05	0.000553	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	7.8e-05	0.000541	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—SMAD3—uterine cancer	7.8e-05	0.000541	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—EP300—uterine cancer	7.77e-05	0.000539	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—FGFR2—uterine cancer	7.44e-05	0.000516	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MTHFR—uterine cancer	7.16e-05	0.000496	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—AKT1—uterine cancer	6.77e-05	0.00047	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP19A1—uterine cancer	6.4e-05	0.000444	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—STK11—uterine cancer	6.4e-05	0.000444	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	6.37e-05	0.000442	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTEN—uterine cancer	6.17e-05	0.000428	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—MTHFR—uterine cancer	5.99e-05	0.000416	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—EP300—uterine cancer	5.89e-05	0.000408	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PIK3CA—uterine cancer	5.75e-05	0.000399	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—EP300—uterine cancer	5.44e-05	0.000377	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—VEGFA—uterine cancer	5.15e-05	0.000357	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—NRAS—uterine cancer	5.09e-05	0.000353	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—MTHFR—uterine cancer	4.81e-05	0.000333	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—AKT1—uterine cancer	4.7e-05	0.000326	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ERBB2—uterine cancer	4.67e-05	0.000324	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—KRAS—uterine cancer	4.38e-05	0.000304	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PIK3CA—uterine cancer	4.36e-05	0.000302	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CDKN1B—uterine cancer	4.32e-05	0.0003	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—CTNNB1—uterine cancer	4.09e-05	0.000283	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PIK3CA—uterine cancer	4.02e-05	0.000279	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTEN—uterine cancer	3.98e-05	0.000276	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—uterine cancer	3.89e-05	0.00027	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EP300—uterine cancer	3.8e-05	0.000263	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—HRAS—uterine cancer	3.72e-05	0.000258	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—AKT1—uterine cancer	3.56e-05	0.000247	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—NRAS—uterine cancer	3.55e-05	0.000246	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTEN—uterine cancer	3.33e-05	0.000231	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—AKT1—uterine cancer	3.29e-05	0.000228	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—EP300—uterine cancer	3.18e-05	0.000221	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KRAS—uterine cancer	3.06e-05	0.000212	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PIK3CA—uterine cancer	2.81e-05	0.000195	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTEN—uterine cancer	2.67e-05	0.000186	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—HRAS—uterine cancer	2.6e-05	0.00018	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—EP300—uterine cancer	2.55e-05	0.000177	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PIK3CA—uterine cancer	2.35e-05	0.000163	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—AKT1—uterine cancer	2.29e-05	0.000159	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—AKT1—uterine cancer	1.92e-05	0.000133	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PIK3CA—uterine cancer	1.89e-05	0.000131	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—AKT1—uterine cancer	1.54e-05	0.000107	CbGpPWpGaD
